Our data show a decreasing trend in the use of systemic glucocorticoids, as well as oral antibiotics for skin infections and hydroxyzine, in parallel with increasing use of methotrexate and dupilumab during the observation period (2016–2020).
← all excerpts
Characterizing Patients and Treatment Patterns in Moderate-to-severe Atopic Dermatitis in Finland: A Population-based Study Using National Health Data.
1
—
—